VectivBio Funding: $145M Raised, Growth (2022)

VectivBio is based in Basel, Switzerland. It has raised $145M in total funding. Latest round: Growth. Backed by Forbion, Citadel, Cormorant Capital.

VectivBio funding overview

VectivBio is based in Basel, Switzerland. VectivBio has raised $145M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in July 2022. The round record for VectivBio runs through 2022; nothing later has been disclosed. Investors on record include Forbion, Citadel, Cormorant Capital, Versant Ventures, OrbiMed. 5 distinct backers are named across the disclosed rounds.

VectivBio at a glance

Total raised
$145M
Latest round
Growth
Latest round date
July 2022
Headquarters
Basel, Switzerland
Notable investors
Forbion, Citadel, Cormorant Capital, Versant Ventures, OrbiMed

Frequently asked about VectivBio funding

How much has VectivBio raised?
VectivBio has raised $145M in total disclosed funding across the rounds on record.
Who has invested in VectivBio?
Forbion, Citadel, Cormorant Capital, Versant Ventures, OrbiMed are named among the investors backing VectivBio.
What was the latest VectivBio funding round?
The most recent disclosed round is a Growth, announced in July 2022.
Where is VectivBio based?
VectivBio is based in Basel, Switzerland.
When did VectivBio last raise?
The last disclosed VectivBio round closed in July 2022 at Growth.

Round data for VectivBio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Basel and backer lists below.

Companies related to VectivBio (33)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026